Objective. The aim of this study was to assess the efficacy of anti-TNF-α therapy in refractory
uveitis due to Behçet’s disease (BD). Methods. We performed a multicentre study of 124 …

… Elia Valls-Pascual , Elia Valls-Pascual … Belén Atienza-Mateo, Vanesa Calvo-Río, Emma
Beltrán, Lucía Martínez-Costa, Elia Valls-Pascual, Marisa Hernández-Garfella, Antonio Atanes, …

Purpose To describe a case of inflammatory chorioretinopathy and Adie’s syndrome
possibly associated with COVID-19. Methods Observational case report. Results A 51-year-old …

Purpose Cystoid macular edema (CME) is a leading cause of blindness. This study assessed
the efficacy and safety of tocilizumab (TCZ) in refractory CME. Design Retrospective case …

Objective To compare the efficacy of infliximab ( IFX ) versus adalimumab ( ADA ) as a first‐line
biologic drug over 1 year of treatment in a large series of patients with refractory uveitis …

Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease
(GD). Our aim was to assess the efficacy and safety of Tocilizumab (TCZ) in GO refractory …

Purpose To assess efficacy, safety, and cost-effectiveness of adalimumab (ADA) therapy
optimization in a large series of patients with uveitis due to Behçet disease (BD) who achieved …

Purpose To study the drug retention rate (DRR), causes, and predictors of discontinuation of
adalimumab (ADA) in a real-world uveitis setting. Design Multicentric, nationwide, registry-…

Objective In a large series of White patients with refractory uveitis due to Behçet disease (BD)
being treated with infliximab (IFX), we assessed (1) long-term efficacy and safety of IFX, …

Objective. Anti-IL6R tocilizumab (TCZ) therapy has proved to be useful in the treatment of
refractory ocular and/or neurological involvement of Behçet’s disease (BD). However, TCZ …